Bearstone Insights Green Paper

The state of medicinal cannabis 2019

Bearstone Insights Green Paper

The state of medicinal cannabis 2019

Who is this report for?

Pharmaceutical companies

Potential investors

Cannabis producers

Medical professionals

Logistics sector

Pharmaceutical
companies

Potential
investors

Cannabis
producers

Medical
professionals

Logistics sector

Germany is a market driver regarding medicinal cannabis. There are more than 15,000 patients in Germany at present, with at least that number again holding unapproved prescriptions from their doctors. For this reason the German market is an exciting one – offering the potential for good returns over time. Germany is not, however, a market for quick speculation.

This report is focused on the changing attitudes and legislative position in Germany, along with the associated opportunities and challenges for investors.